Energy conversion efficiency in low- and atmospheric-pressure plasma polymerization processes with hydrocarbons.

Since the earliest days of this field there has been an interest in correlating the structure of plasma polymer (PP) coatings with deposition parameters, most particularly with energy input per monomer molecule, Em. Both of our laboratories have developed methods for measuring Em (or somewhat equivalent, the apparent activation energy, Ea) in low- (LP) and atmospheric-pressure (AP) electrical discharge plasmas. We recently proposed a new parameter, energy conversion efficiency (ECE), which for the first time permits direct comparison of LP and AP experiments. Here, we report the case of small hydrocarbons, namely acetylene, ethylene and methane. "Critical" Em (or Ea) values that demarcate ECE regimes separating different reaction mechanisms are found to agree remarkably well, and to correlate with specific reaction mechanisms, including dissociation, recombination, gas-phase oligomerization, and surface processes.

Energetics of Molecular Excitation, Fragmentation, and Polymerization in a Dielectric Barrier Discharge with Argon Carrier Gas.

We report experiments at atmospheric pressure (AP) using a dielectric barrier discharge (DBD) reactor designed for plasma polymerization (PP) with "monomers" at ‰ concentrations in ca.10 standard liters per minute of argon (Ar) carrier gas. We have perfected a method for measuring Eg, the energy dissipated per cycle of the applied a.c. high voltage, Va(f), but the focus here is on ΔEg, the energy difference with and without a flow, Fd, of monomer in the Ar flow, with the plasma being sustained at Va(f) = 2.8 kVrms, f = 20 kHz. From ΔEg and Fd, we derive a characteristic energy per molecule, Em (in eV), and investigate plots of Em versus Fd and 1/Fd for three model "monomers": formic, acetic, and acrylic acid. These data, along with those for lighter or heavier organic compounds, reveal novel information about energy absorption from the plasma and ensuing polymerization reactions.

A novel 3D co-culture platform for integrating tissue interfaces for tumor growth, migration and therapeutic sensitivity: "PP-3D-S".

Metastatic cancers can be highly heterogeneous, show large patient variability and are typically hard to treat due to chemoresistance. Personalized therapies are therefore needed to suppress tumor growth and enhance patient's quality of life. Identifying appropriate patient-specific therapies remains a challenge though, due mainly to non-physiological in vitro culture systems. Therefore, more complex and physiological in vitro human cancer microenvironment tools could drastically aid in development of new therapies. We developed a plasma-modified, electro-spun 3D scaffold (PP-3D-S) that can mimic the human cancer microenvironment for customized-cancer therapeutic screening. The PP-3D-S was characterized for optimal plasma-modifying treatment and scaffolds morphology including fiber diameter and pore size. PP-3D-S was then seeded with human fibroblasts to mimic a stromal tissue layer; cell adhesion on plasma-modified poly (lactic acid), PLA, electrospun mats vastly exceeded that on untreated controls. The cell-seeded scaffolds were then overlaid with alginate/gelatin-based hydrogel embedded with MDA-MB231 human breast cancer cells, representing a tumor-tissue interface. Among three different plasma treatments, we found that NH3 plasma promoted the most tumor cell migration to the scaffold surfaces after 7 days of culture. For all treated and non-treated mats, we observed a significant difference in tumor cell migration between small-sized and either medium- or large-sized scaffolds. In addition, we found that the PP-3D-S was highly comparable to the standard Matrigel® migration assays in two different sets of doxorubicin screening experiments, where 75% reduction in migration was achieved with 0.5 µM doxorubicin for both systems. Taken together, our data indicate that PP-3D-S is an effective, low-cost, and easy-to-use alternate 3D tumor migration model which may be suitable as a physiological drug screening tool for personalized medicine against metastatic cancers.

Study of plasma modified-PTFE for biological applications: relationship between protein resistant properties, plasma treatment, surface composition and surface roughness.

PTFE samples were treated by low-pressure, O2 RF plasmas. The adsorption of BSA was used as a probe for the protein resistant properties. The exposure of PTFE to an O2 plasma leads to an increase in the chamber pressure. OES reveals the presence of CO, CO2 and F in the gas phase, indicating a strong etching of the PTFE surface by the O2 plasma. Furthermore, the high resolution C1s spectrum shows the appearance of CF3, CF and C-CF components in addition to the CF2 component, which is consistent with etching of the PTFE surface. WCA as high as 160° were observed, indicating a superhydrophobic behaviour. AFM Images of surfaces treated at high plasma power showed a increase in roughness. Lower amounts of BSA adsorption were detected on high power, O2 plasma-modified PTFE samples compared to low power, oxygen plasma-modified ones.